Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

tolazamide

An intermediate-acting, first-generation sulfonylurea with hypoglycemic activity. Tolazamide is converted into five major metabolites that are excreted into the urine. Tolazamide is more potent than tolbutamide and similar in potency to chlorpropamide on a milligram basis. This agent may cause cholestatic jaundice.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Norglycin
Tolinase
Code name:U-17835
Chemical structure:1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea
4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide
NSC code:70762
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search